Date
Title
View
10 Feb 20
4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares
View
21 Jan 20
4basebio AG: 4basebio AG decides to buy back 2 million treasury shares for further use in accordance with the authorizing resolution
View
11 Nov 19
Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business
View
29 Oct 19
Expedeon AG: Expedeon AG raises adjusted EBITDA guidance for 2019
View
14 Mar 19
Expedeon AG: Expedeon Announces Supervisory Board Changes
View
18 May 18
SYGNIS AG: SYGNIS raises revenue guidance for 2018 after closing the acquisition of TGR Biosciences
View
02 May 18
SYGNIS AG: – Sygnis obtains finance to close the acquisition of the Australian TGR Biosciences PTY LTD –
View
20 Mar 18
SYGNIS AG: SYGNIS AG raise approximately EUR 4.2 million in private placement
View
19 Mar 18
Correction of a release from 19.03.2018, 17:55 CET/CEST – SYGNIS AG: SYGNIS AG to raise capital via a private placement of new shares to acquire TGR Biosciences
View
19 Mar 18
SYGNIS AG: SYGNIS AG to raise capital via a private placement of new shares to acquire TGR Biosciences
View
05 Jun 17
SYGNIS AG: SYGNIS AG announces management changes
View
30 May 17
SYGNIS AG: SYGNIS AG successfully completes Rights Offering and Private Placement
View